Skip to content
lsd.com

South Carolina

Psychedelic trials in South Carolina

20 registered trials has a study site in South Carolina, and 1 is recruiting now.

20
Trials with a site here
1
Recruiting
9
Facilities

Open now

Recruiting in this state

TrialStatusPhaseSubstanceSites
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 · Definium Therapeutics US, Inc.RecruitingPhase 3lsd30

Facilities

Where the research happens in South Carolina

FacilityCityTrials
Zen Therapeutic Solutions, LLCMt. Pleasant4
Medical University of South CarolinaCharleston3
Offices of Michael MithoeferMt. Pleasant3
Offices of Michael Mithoefer MDMt. Pleasant2
Coastal Carolina ResearchNorth Charleston1
Coastal Carolina Research CenterNorth Charleston1
Prisma HealthGreenville1
Medical University of South Carolina CenterspaceCharleston1
Zen Therapeutic SolutionsMt. Pleasant1

Stay told

When a trial opens in South Carolina

Research alerts

Get a notification when a trial for trials in South Carolina starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

All trials

Every trial with a South Carolina site

TrialStatusPhaseSubstanceSites
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689 · Definium Therapeutics US, Inc.RecruitingPhase 3lsd30
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228 · Definium Therapeutics US, Inc.Active, not recruitingPhase 3lsd34
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)NCT03537014 · Resilient PharmaceuticalsCompletedPhase 3mdma15
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)NCT04077437 · Resilient PharmaceuticalsCompletedPhase 3mdma14
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSDNCT04714359 · Resilient PharmaceuticalsCompletedPhase 3mdma15
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant DepressionNCT02497287 · Janssen Research & Development, LLCCompletedPhase 3ketamine109
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionNCT02782104 · Janssen Research & Development, LLCCompletedPhase 3ketamine173
54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideNCT03039192 · Janssen Research & Development, LLCCompletedPhase 3ketamine56
Ketamine for Methamphetamine Use DisorderNCT06496750 · University of Texas Southwestern Medical CenterActive, not recruitingPhase 2ketamine5
MDMA-Assisted Psychotherapy in People With Posttraumatic Stress DisorderNCT00090064 · Resilient PharmaceuticalsCompletedPhase 2mdma1
Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress DisorderNCT01211405 · Resilient PharmaceuticalsCompletedPhase 2mdma1
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSDNCT03282123 · Resilient PharmaceuticalsCompletedPhase 2mdma12
MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSDNCT02876172 · Resilient PharmaceuticalsCompletedPhase 1 / Phase 2mdma1
A Study of Ketamine in Patients With Treatment-resistant DepressionNCT01627782 · Janssen Research & Development, LLCCompletedPhase 2ketamine13
Ketamine for the Treatment of Opioid Use Disorder and DepressionNCT04177706 · Medical University of South CarolinaCompletedPhase 2ketamine1
KAP for Depression in Abstinent Opioid UsersNCT05193318 · Medical University of South CarolinaTerminatedPhase 2ketamine1
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy TrialNCT01458327 · Resilient PharmaceuticalsCompletedPhase 2mdma1
Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy VolunteersNCT01404754 · Resilient PharmaceuticalsCompletedPhase 1mdma3
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use DisorderNCT05796791 · Medical University of South CarolinaCompletedEarly Phase 1ketamine1
Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSDNCT02102802 · Resilient PharmaceuticalsCompletedN/Amdma1

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states